ElMindA was founded in 2006, with the vision of revolutionizing the management of brain disorders and injuries, by transforming state of the art neuroscience into bed-side clinical practice, opening a new window into our brain’s functionality, and enabling well-informed clinical decision making.Our mission is to bring to market a paradigm changing platform technology for daily practical use that will:Dramatically improve clinical decision making for CNS disease management through wide utilization of BNA™ testing as an objective measurement of brain function, dysfunction, disease progression and recoveryTransform drug development and discovery by reducing the risk of failed trials, improving results and saving significant time and money for developersElMindA has developed the BNA™ technology platform, which for the first time allows high resolution visualization and evaluation of the complex neuro-physiological interconnections of the human brain at work, capturing information on the composition, connectivity, synchronization and operation of brain networks.